Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma

NCT00469469 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped unable to enroll subjects into the study

Conditions

Adrenocortical Carcinoma

Interventions

DRUG: Bevacizumab

Sponsor

Dartmouth-Hitchcock Medical Center

Collaborators

[object Object]